You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Urinary albumin creatinine ratio

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial (HBA1C, Lipid profile, including total, LDL, and HDL cholesterol and Triglycerides, Urine analysis and

Not yet recruiting
  • Type 2 Diabetes
  • HBA1C
  • +8 more
  • (no location specified)
May 16, 2023

Role of Estrogen in the Flarring up of Lupus Nepheritis

Unknown status
  • Activity of Lupus Nepheritis
  • serum estrogen and urinary albumin creatinine ratio
  • (no location specified)
Jul 8, 2020

T2DM (Type 2 Diabetes), Metformin, SGLT2-Inhibitors Trial in Matsumoto (Tofogliflozin, Metformin)

Recruiting
  • T2DM (Type 2 Diabetes Mellitus)
  • +2 more
  • Matsumoto, Nagano, Japan
    Shinshu University
Jul 21, 2022

Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD

Not yet recruiting
  • Diabetic Kidney Disease
  • cathepsin S and chromogranin A
  • (no location specified)
Oct 5, 2023

"Association of Proteinuria and Progression of Kidney

Completed
  • Change in Albumin to Creatinine Ratio and Glomerular Filtration Rate
  • Progression of Kidney Failure and or All-cause Mortality
  • no intervention study
  • Creteil, France
    Henri Mondor Hospital
Jun 1, 2022

Reference Interval of Spot Urinary Oxalate to Creatinine Ratio

Completed
  • Hyperoxaluria
    • Karachi, Sindh, Pakistan
      Syed bilal hashmi
    Feb 15, 2021

    Diabetic Nephropathies Trial in Tanta (Niclosamide, Placebo oral tablet)

    Completed
    • Diabetic Nephropathies
    • Tanta, Egypt
      Faculty of Pharmacy, Tanta University
    Oct 19, 2022

    Chronic Kidney Disease and Non-alcoholic Fatty Liver Diseases

    Completed
    • Chronic Kidney Diseases
    • NAFLD
    • urinary albumbin/creatinine ratio
    • Sohag, Egypt
      Mona Mohammed Abdelrahman
    Nov 1, 2021

    Urolithiasis, Hyperoxaluria Trial in Karachi (Oxalate to creatinine ratio)

    Completed
    • Urolithiasis
    • Hyperoxaluria
    • Oxalate to creatinine ratio
    • Karachi, Pakistan, Sindh, Pakistan
      Syed bilal hashmi
    Sep 30, 2020

    Diabetic Kidney Disease Trial in United States (TMX-049, Placebo)

    Completed
    Has Results
    • Diabetic Kidney Disease
    • Flagstaff, Arizona
    • +54 more
    Jul 28, 2022

    Coronary Microvascular Dysfunction in Chronic Kidney Disease

    Unknown status
    • Kidney Disease, Chronic
    • Myocardial Dysfunction
    • Coronary flow reserve assessment
    • +4 more
    • Birmingham, United Kingdom
      Queen Elizabeth Hospital
    Jul 8, 2019

    Novel Antidiabetic Drug Combined With Angiotensin

    Recruiting
    • Type 2 Diabetes
    • Antidiabetic Drugs
      • Beijing, Beijing, China
      • +1 more
      Jun 20, 2023

      Chronic Kidney Diseases Trial (Empagliflozin 10 MG, Placebo)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Empagliflozin 10 MG
      • Placebo
      • (no location specified)
      Oct 30, 2023

      Chronic Kidney Disease Trial in Worldwide (Verinurad, Allopurinol, Placebo for Verinurad)

      Completed
      • Chronic Kidney Disease
      • Huntsville, Alabama
      • +165 more
      Jan 19, 2022

      Heart Failure, Type 2 Diabetes Trial in Dundee (Empagliflozin 25mg, Placebo oral capsule, Frusemide)

      Completed
      Has Results
      • Heart Failure
      • Type 2 Diabetes Mellitus
      • Empagliflozin 25mg
      • +2 more
      • Dundee, Angus, United Kingdom
        University of Dundee, Ninewells Hospital and Medical School
      Jun 22, 2021

      Primary IgA Nephropathy Trial (SHR-2010 Injection, Placebo)

      Not yet recruiting
      • Primary IgA Nephropathy
      • SHR-2010 Injection
      • Placebo
      • (no location specified)
      Apr 27, 2023

      Early Screening and Diagnosis of CKD

      Recruiting
      • Kidney; Disease (Functional)
      • Chronic Kidney Disease
      • 99mTc-DTPA
      • Nanjing, Jiangsu, China
        Nanjing First Hospital, Nanjing Medical University
      Apr 5, 2022

      Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of

      Active, not recruiting
      • Diabetic Nephropathy
      • Grouping based on previous laboratory results, no intervention.
      • Jinan, Shandong, China
        Qianfoshan Hospital
      Oct 24, 2023

      Diabetes, Microalbuminuria Trial in Seoul (semi-quantitative urine albumin-to-creatinine ratio test, standard quantitative spot

      Completed
      • Diabetes
      • Microalbuminuria
      • semi-quantitative urine albumin-to-creatinine ratio test
      • standard quantitative spot urine albumin-to-creatinine ratio
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 24, 2020

      Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation

      Active, not recruiting
      • Diabetic Nephropathy
      • Grouping based on previous laboratory results, no intervention.
      • Jinan, Shandong, China
        Qianfoshan Hospital
      Nov 8, 2023

      Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Vitamin K 2
      • (no location specified)
      Jul 4, 2023

      Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)

      Not yet recruiting
      • Chronic Kidney Diseases
      • Placebo
      • Co-Enzyme Q10
      • (no location specified)
      Jul 4, 2023

      Chronic Kidney Disease Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

      Recruiting
      • Chronic Kidney Disease
      • Huntsville, Alabama
      • +251 more
      Dec 22, 2022

      Diabetic Nephropathies Trial in Daegu (CU01-1001, Placebo)

      Recruiting
      • Diabetic Nephropathies
      • Daegu, Korea, Republic of
        Yeongnam University Medical Center
      Feb 6, 2023

      Heart Failure, Chronic Kidney Disease Trial in Worldwide (AZD9977, Dapagliflozin)

      Recruiting
      • Heart Failure
      • Chronic Kidney Disease
      • Hot Springs National Park, Arkansas
      • +279 more
      Feb 1, 2023